MedTrace Logo

The HIFUB Study (HIFU in Breast Cancer)

NCT05350059 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-04-27

No results posted yet for this study

Summary

High Intensity Focused Ultrasound (HIFU) is a new method of treating solid tumours by thermally ablating them. It has been used in a number of different types of cancers but there is little information on its use in invasive breast cancer (IBC). The investigators aim to assess the efficacy and safety of HIFU in the treatment of IBC.

In this study, fifteen otherwise healthy women diagnosed with small, early stage IBC will be treated with HIFU prior to conventional surgical treatment. The effects of HIFU on the resected tumour will be analysed pathologically and correlated with radiological findings. Immune response and participant experience will also be evaluated

Conditions

Interventions

DEVICE

High Intensity Focused Ultrasound (HIFU) to the Breast Cancer

Breast cancer will be ablated using high intensity frequency ultrasound prior to breast surgery

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Gurdeep S Mannu, MRCSEd DPhil · University of Oxford

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2022-09-01
Completion
2022-11-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05350059 on ClinicalTrials.gov